Sonio
Explore this company’s associated devices, FDA decisions and regulatory history.

Sonio
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Sonio. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 16, 2026 to Jun 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code IYN appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 147 Rue D'Aboukir, Paris, 750002, FR. Recorded on K261519, decision dated Jun 4, 2026.
Device categories in this collection
Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer; System, Imaging, Pulsed Doppler, Ultrasonic.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sonio SuspectK261519 | Sonio | 510(k) clearance | Jun 4, 2026 | FDA |
Sonio Detect (v3)K252433 | Sonio | 510(k) clearance | Mar 16, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.

